F 0677
Provide care and assistance to perform activities of daily living for any resident who is unable.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review, the facility failed to provide timely incontinence care to
a dependent resident (R4) for one out of ten residents reviewed for Activities of Daily Living (ADL) care.
Residents Affected - Few
Findings include:
R4's face sheet documents medical diagnoses of lack of coordination and weakness.
R4's comprehensive care plan, last revised 9/12/2023, documents R4 has limited physical mobility related
to weakness and decreased energy. Intervention, dated 9/12/2023, documents R4 requires one to two staff
assist with ADL/mobility task.
On 9/26/2023 at 11:56 AM, R4 was alert and oriented to person, place, and month. R4 stated staff
sometimes take a long time to answer call lights and carry out the care requested. R4 stated this results in
R4 lying in a urine-soaked incontinence product for one to two hours.
At 1:43 PM, R4 was lying in bed, and stated needing staff assistance for incontinence care. R4 pressed the
call light at 1:44 PM.
At 1:45 PM, V6 (Nurse) answered the call light. R4 requested assistance with incontinence care. V6 left the
room and notified V7 (Certified Nurse Assistant, CNA).
V7 did not provide incontinence care to R4 until 2:32 PM.
On 09/28/2023 at 1:36 PM, V2 (Director of Nursing) stated CNAs should perform incontinence care within
10-15 minutes from the time the resident requests it.
Facility's Activities of Daily Living (ADLs), Supporting policy, last revised 3/2018, documents:
Residents who are unable to carry out activities of daily living independently will receive the services
necessary to maintain good nutrition, grooming and personal and oral hygiene.
Appropriate care and services will be provided for residents who are unable to carry out ADLs
independently, with the consent of the resident and in accordance with the plan of care, including
appropriate support and assistance with:
1.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
145659
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145659
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/29/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Waterford Care Center, The
7445 North Sheridan Road
Chicago, IL 60626
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0677
Hygiene (bathing, dressing, grooming, and oral care);
Level of Harm - Minimal harm
or potential for actual harm
2.
Mobility (transfer, bed mobility and ambulation, including walking);
Residents Affected - Few
3.
Elimination (toileting);
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145659
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145659
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/29/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Waterford Care Center, The
7445 North Sheridan Road
Chicago, IL 60626
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview, and record review, the facility failed to provide an antiretroviral medication for a resident
with Human Immunodeficiency Virus (HIV), and failed to notify the prescribing physician the medication was
not available to the resident for one (R2) of ten residents reviewed for medications.
Residents Affected - Few
Findings include:
R2's face sheet documents medical diagnosis of HIV disease.
R2's physicians' order sheets document an order for Abacavir-Dolutegravir-Lamivud Tablet 600-50-300 MG
(milligram) Give 1 tablet by mouth at bedtime for HIV infection.
On 9/26/2023 at 11:32 AM, R2 was alert and oriented to person, place, and date. R2 stated R2 recently
restarted the antiretroviral medication after R2's appointment with V18 (Infectious Disease Doctor) on
9/05/2023. R2 stated R2 was off the medication for a few months because the facility did not have it, and
did not get it from the pharmacy.
R2's September Medication Administration Records (MAR) document a charting code of 9 for
9/01/2023-9/03/2023 for R2's Abacavir-Dolutegravir-Lamivud. Per MAR Chart Codes, 9 indicates Other /
See Progress Notes. Surveyor reviewed R2's MARs from April through September. Staff charted 9 for most
of the dates for the antiretroviral medication.
Progress notes, dated 9/02/2023 9:20 PM and 9/03/2023 9:58 PM, document
Abacavir-Dolutegravir-Lamivud was not available. Multiple progress notes from May through September
document it was not available. Progress note from 4/14/2023 documents it was not available.
On 9/26/2023 at 11:38 AM, V4 (Nurse) stated R2 was not taking the antiretroviral medication for a few
months. V4 stated medication was not refilled until 9/05/2023. V4 showed surveyor the printed label with the
dispense date on R2's medication bottle; Dispensed 9/05/2023.
On 9/27/2023 at 12:58 PM, V16 (Social Service Director) stated Illinois's AIDS (Acquired Immunodeficiency
Syndrome) Assistance Program (ADAP) provides coverage for R2's antiretroviral mediation. V16 stated
there was a lapse in coverage; therefore, the pharmacy did not refill the medication. V16 stated V16 did not
know if V18 (Infectious Disease Doctor) or V19 (R2's Primary Physician) were aware the pharmacy did not
fill the medication, or that R2 has not taken it for months.
On 9/27/2023 at 1:24 PM, V17 (Nurse Practitioner) stated staff did not notify V17 that pharmacy did not
refill R2's Abacavir-Dolutegravir-Lamivud from April until September. Staff did not notify V17 it was not
available for a prolonged time. V17 stated R2 needs to take the antiretroviral medication because it will help
increase R2's mortality. If R2 does not take the medication, then it increases R2's chances of getting AIDS
and being in the end stage of HIV. V17 stated R2's life will be shortened if R2 does not take it.
On 9/28/2023 at 1:51 PM, V18 stated the facility did not notify V18 that R2's Triumeq (brand name for
Abacavir-Dolutegravir-Lamivud) was not available, and R2 was off the medication for months. V18 stated
the medication's purpose is to have an undetectable viral load in the patient, maintain or raise a patient's
CD4 count, and maintain health. V18 stated when V18's office conducted blood work on
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145659
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145659
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/29/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Waterford Care Center, The
7445 North Sheridan Road
Chicago, IL 60626
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
R2 on 9/05/2023, R2's viral load was high, which was an indication that either R2 was not taking HIV
medications, or that there was viral resistance. V18 stated R2's CD4 count on 9/05/2023 was also lower
compared to R2's results from 4/13/2023. V18 stated if R2 is not taking the medication, R2 is at risk for the
development of opportunistic infections.
On 9/28/2023 at 2:01 PM, V2 (Director of Nursing) stated if a specialty medication such as R2's
antiretroviral medication is not available, the nurse should call the doctor and get an order to see if there is
any alternative. V2 stated staff did not notify V2 if this was done.
Facility's Administering Medications policy, last revised 4/2019, documents in part:
Medications are administered in a safe and timely manner, and as prescribed.
Medications are administered in accordance with prescriber orders, including any required time frame.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145659
If continuation sheet
Page 4 of 4